NCT02008916 - 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients | Biotech Hunter

Enrollment

226

Participants

Timeline

Start Date

January 14, 2014

Primary Completion Date

February 23, 2015

Study Completion Date

December 11, 2017

Conditions

Spondylitis, Ankylosing

Interventions

DRUG

Secukinumab

AIN457 (Secukinumab) is a human monoclonal antibody. Secukinumab binds and reduces the activity of Interleukin 17 (IL-17).

DRUG

Placebo secukinumab

Placebo to AIN457 (Secukinumab)

Trial Locations (57)

1070

Novartis Investigative Site, Brussels

9300

Novartis Investigative Site, Aalst

12203

Novartis Investigative Site, Berlin

12206

Novartis Investigative Site, Albany

13125

Novartis Investigative Site, Berlin

14004

Novartis Investigative Site, Córdoba

15006

Novartis Investigative Site, A Coruña

16635

Novartis Investigative Site, Duncansville

18209

Novartis Investigative Site, Bad Doberan

21100

Novartis Investigative Site, Mexicali

22081

Novartis Investigative Site, Hamburg

27000

Novartis Investigative Site, Torreón

28046

Novartis Investigative Site, Madrid

29460

Novartis Investigative Site, Charleston

30120

Novartis Investigative Site, El Palmar

30625

Novartis Investigative Site, Hanover

33026

Novartis Investigative Site, Pembroke Pines

34684

Novartis Investigative Site, Palm Harbor

36604

Novartis Investigative Site, Mobile

37075

Novartis Investigative Site, Göttingen

38305

Novartis Investigative Site, Jackson

39008

Novartis Investigative Site, Santander

39110

Novartis Investigative Site, Magdeburg

39261

Novartis Investigative Site, Zerbst

44649

Novartis Investigative Site, Herne

73103

Novartis Investigative Site, Oklahoma City

75150

Novartis Investigative Site, Mesquite

78731

Novartis Investigative Site, Austin

80000

Novartis Investigative Site, Culiacan

81541

Novartis Investigative Site, München

85202

Novartis Investigative Site, Mesa

85381

Novartis Investigative Site, Peoria

91054

Novartis Investigative Site, Erlangen

91056

Novartis Investigative Site, Erlangen

91786

Novartis Investigative Site, Upland

115522

Novartis Investigative Site, Moscow

190068

Novartis Investigative Site, Saint Petersburg

197022

Novartis Investigative Site, Saint Petersburg

420097

Novartis Investigative Site, Kazan'

07055

Novartis Investigative Site, Passaic

686 01

Novartis Investigative Site, Uherské Hradiště

128 50

Novartis Investigative Site, Prague

03042

Novartis Investigative Site, Cottbus

07740

Novartis Investigative Site, Jena

115 27

Novartis Investigative Site, Athens

564 29

Novartis Investigative Site, Thessaloniki

115 21

Novartis Investigative Site, Athens

700 13

Novartis Investigative Site, Heraklion

2801 951

Novartis Investigative Site, Almada

1050-034

Novartis Investigative Site, Lisbon

1349-019

Novartis Investigative Site, Lisbon

1649-035

Novartis Investigative Site, Lisbon

08208

Novartis Investigative Site, Sabadell

E11 1NR

Novartis Investigative Site, London

NR4 7UY

Novartis Investigative Site, Norwich

TQ2 7AA

Novartis Investigative Site, Torquay